KYG5961B1041
KYG5961B1041
MEDLIVE
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 642.155.000 | 558.455.000 | 15.0% |
| Cost of Revenue | 256.715.000 | 231.233.000 | 11.0% |
| Gross Profit | 385.440.000 | 327.222.000 | 17.8% |
| 212.990.000 | 205.201.000 | 3.8% | |
| Operating Income | 172.450.000 | 122.021.000 | 41.3% |
| Pretax Income | 360.288.000 | 340.474.000 | 5.8% |
| Net Income Common Stockholders | 334.341.000 | 315.146.000 | 6.1% |
| -- | -- | -- | |
| -- | -- | -- |